BioVariance Blog

Success at TOP 100: Ranga Yogeshwar honors BioVariance

Ranga Yogeshwar congratulated BioVariance GmbH from Waldsassen on its success in the TOP 100 innovation competition with a personal video on 26.11.2021. In addition, the science journalist recognized the achievements of this year’s TOP 100

BioVariance gains TOP 100 award

Waldsassen, 10.02.2021 BioVariance GmbH from Waldsassen gained the TOP 100 award 2021, which is given to highly innovative medium-sized companies once a year – now for the 28th time. Before, BioVariance proved its innovative power in

TubeLab facilitates laboratory routine

Waldsassen – BioVariance finishes the development of TubeLab, a software for the organisation of multi-level laboratory processes. To ensure an effective performance of the workflow, TubeLab was developed in cooperation with a renowned diagnostics laboratory.

OncoVariant automates the drug search for oncologists

Waldsassen – BioVariance has finished the development of the platform OncoVariant for the interpretation of genetic variants in cancer patients. Thereby, the crucial search for suitable drugs is simplified and accelerated significantly. „Using OncoVariant, the oncologist

HORIZON 2020 – REVERT

Waldsassen – BioVariance has received a commitment for the project REVERT from the European Commission as part of HORIZON 2020, the EU framework program for research and innovation. The project goal is to identify the

For the research of DIPG across 14 countries

DIPG (diffuse intrinsic pontine glioma) describes a brain tumor in children for which there exists no cure or positive life-changing treatment. Even if this type of pontine glioma can be classified as “rare diseases”, it